Protocol No
GIM-PCORI-PRECIDENTD
Phase
IV
Summary
A trial designed to compare rates of the total number of cardiovascular, kidney, and death events among three alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCV.
Description
PREvention of Cardovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov